Author

I. Maricic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:proteomics· 2 Organism:rat· 2 Approach:deep learning· 1 Assay:DNA methylation· 1

Frequent Co-Authors

D. B. Weiner· 4 shared K. Schultheis· 4 shared A. Doan· 3 shared D. Elwood· 3 shared J. J. Kim· 3 shared K. E. Broderick· 3 shared L. M. Humeau· 3 shared M. Purwar· 3 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

D. B. Weiner

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates

J. N. Walters, B. Schouest, A. Patel, E. L. Reuschel, K. Schultheis, E. Parzych, I. Maricic, E. N. Gary, M. Purwar, V. M. Andrade, A. Doan, D. Elwood, Z. Eblimit, B. Nguyen, D. Frase, , K. E. Broderick

bioRxiv · Oct 27, 2021Immunology

Design, immunogenicity and efficacy of a Pan-SARS-CoV-2 synthetic DNA vaccine

C. C. Reed, K. Schultheis, V. M. Andrade, R. Kalia, J. Tur, B. Schouest, D. Elwood, J. N. Walters, I. Maricic, A. Doan, M. Vazquez, Z. Eblimit, P. Pezzoli, D. Amante, M. Porto, , K. E. Broderick

This study designs and tests a DNA vaccine, INO-4802, which induces broad immunity against multiple SARS-CoV-2 variants in animal models.

bioRxiv · May 11, 2021 · PreprintImmunology

Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drive rapid and potent immunogenicity capable of single-dose protection

K. Konrath, K. Liaw, Y. Wu, X. Zhu, S. Walker, Z. Xu, K. Schultheis, N. Chokkalingam, N. J. Tursi, J. Du, M. Sullivan, M. Purwar, A. Moore, V. Machado, I. Maricic, , D. W. Kulp

This study develops glycan-modified SARS-CoV-2 nanoparticle vaccines that induce potent neutralizing antibodies and single-dose protection against SARS-CoV-2 in multiple animal models.

bioRxiv · Apr 28, 2021Immunology

Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model

A. Patel, J. Walters, E. L. Reuschel, K. Schultheis, E. Parzych, E. N. Gary, I. Maricic, M. Purwar, Z. Eblimit, S. N. Walker, D. Guimet, P. Bhojnagarwala, A. Doan, Z. Xu, D. Elwood, , K. E. Broderick

This study evaluates an intradermal DNA vaccine against SARS-CoV-2 in rhesus macaques, showing it induces immune responses and provides protection against viral challenge.

bioRxiv · Jul 28, 2020 · PreprintImmunology